Century Therapeutics, Inc. develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, which targets CD19 for relapsed, refractory B-cell lymphoma. It is also developing a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma.
| Market Cap | 120.353 Million | Shares Outstanding | 59.581 Million | Avg 30-day Volume | 84.311 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.54 |
| Price to Revenue | 41.0242 | Debt to Equity | 0.0 | EBITDA | -115.171 Million |
| Price to Book Value | 0.7563 | Operating Margin | -2896.6258 | Enterprise Value | -113.744 Million |
| Current Ratio | 8.417 | EPS Growth | -14.5 | Quick Ratio | 8.162 |
| 1 Yr BETA | 1.1416 | 52-week High/Low | 11.95 / 1.95 | Profit Margin | -2782.3401 |
| Operating Cash Flow Growth | -843.3258 | Free Cash Flow to Firm (FCFF) TTM | -100.452 Million | Free Cash Flow to Equity (FCFE) TTM | -118.112 Million |
| Altman Z-Score | -1.8825 | ||||
| Earnings Report | 2023-11-09 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
0 | 2023-06-27 | 1 | |
|
0 | 2023-06-27 | 1 | |
|
0 | 2023-06-27 | 3 | |
|
0 | 2023-06-27 | 3 | |
|
0 | 2023-06-27 | 1 | |
|
0 | 2023-06-27 | 1 | |
|
0 | 2023-06-27 | 1 | |
|
DIEM MICHAEL CRAIG CHIEF FINANCIAL OFFICER |
|
274,296 | 2023-05-15 | 2 |
|
CARR DOUGLAS SVP FINANCE & OPERATIONS |
|
321,391 | 2023-05-15 | 2 |
|
LEVITSKY HYAM PRESIDENT OF R&D |
|
0 | 2023-04-12 | 2 |
|
RUSSOTTI GREGORY CHIEF TECHNOLOGY OFFICER |
|
0 | 2023-04-11 | 2 |
|
BORGES LUIS CHIEF SCIENTIFIC OFFICER |
|
256,535 | 2023-04-03 | 3 |
|
FLORES OSVALDO CHIEF EXECUTIVE OFFICER |
|
0 | 2023-02-02 | 1 |
|
FARID ADRIENNE CHIEF OPERATIONS OFFICER |
|
117,968 | 2023-02-02 | 1 |
|
VERSANT VENTURE CAPITAL VI, L.P. |
|
12,166,109 | 2022-08-09 | 0 |
|
19,872 | 2022-06-09 | 0 | |
|
12,675,838 | 2021-06-22 | 0 | |
|
FUJIFILM CELLULAR DYNAMICS, INC. |
|
6,955,207 | 2021-06-22 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 22:15:03 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 21:45:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 21:15:03 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 20:45:05 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 20:15:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 19:45:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 19:15:03 UTC | 0.0 | 0.0 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 18:45:03 UTC | 0.0 | 0.0 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 18:15:03 UTC | 0.0 | 0.0 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 17:45:03 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 17:15:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 16:45:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 16:15:03 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 15:45:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 15:15:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 14:45:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 14:15:04 UTC | 4.2446 | 1.0754 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 13:45:03 UTC | 4.3339 | 0.9861 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 13:15:04 UTC | 4.3339 | 0.9861 | 1100000 |
| CENTURY THERAPEUTICS INC IPSC | 2023-09-29 12:45:05 UTC | 4.3339 | 0.9861 | 1100000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
